Clal Biotechnology reported ILS158.39M in Assets for its fiscal quarter ending in December of 2023.


Assets Change Date
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 106.52M 8.48M Jun/2025
Life Technologies USD 101.53M 4.7M Jun/2025
RedHill Biopharma USD 18.04M 3.98M Dec/2024